# ClinChoice

> ClinChoice is a mid-size, global, full-service contract research organization (CRO) that helps pharmaceutical, biotech, medical device, and consumer health companies run clinical trials and bring drugs and devices to market. Founded in 1995 and headquartered in Horsham, Pennsylvania, the firm employs roughly 4,000 people across the Americas, Europe, and Asia-Pacific, offering clinical development, biometrics, safety/pharmacovigilance, regulatory affairs, post-marketing real-world evidence, and technology services. After rebranding from Fountain Medical Development (FMD K&L) in 2020 and raising a $150M Series E in 2022, ClinChoice has grown through acquisitions to serve six of the top ten pharma companies while focusing on emerging and mid-size biotech innovators.

- **Founded:** 1995
- **Headquarters:** Horsham, Pennsylvania, United States
- **Founders:** Xin Ke (Co-Founder / Board Member), John D. Balian (Co-Founder / CEO (ClinChoice Inc.))
- **Team size:** ~4,000 employees (company cites 3,000+ global experts)
- **Products:** Clinical Development, Biometrics, Safety & Pharmacovigilance, Regulatory Affairs & Medical Writing, Post-Marketing & Real-World Evidence
- **Notable:** Grew from Fountain Medical Development (FMD K&L) into the unified ClinChoice brand in 2020., Raised a $150M Series E in 2022 led by Legend Capital., Delivered 3,000+ clinical studies since 2010 and 10,000+ regulatory submissions.

## Products & services

- **Clinical Development** — Full-service clinical operations including study start-up, monitoring, medical monitoring, and trial management across all phases.
- **Biometrics** — Biostatistics, data management, statistical programming, and data science supporting clinical and regulatory decisions.
- **Safety & Pharmacovigilance** — Drug safety, pharmacovigilance, and product vigilance services across the product lifecycle.
- **Regulatory Affairs & Medical Writing** — Regulatory strategy, submissions, and scientific/medical writing; 10,000+ regulatory submissions delivered.
- **Post-Marketing & Real-World Evidence** — Late-phase, observational, and real-world evidence studies supporting marketed products.
- **Functional Service Provider (FSP) Solutions** — Flexible resourcing model where ClinChoice staff embed within sponsor teams to deliver specific functions.
- **Technology & eClinical** — Clinical systems, data visualization, and data science platforms supporting trial delivery.
- **Consulting** — Strategic and operational consulting for pharma, biotech, medical device, and consumer health clients.

## Achievements

- Grew from Fountain Medical Development (FMD K&L) into the unified ClinChoice brand in 2020.
- Raised a $150M Series E in 2022 led by Legend Capital.
- Delivered 3,000+ clinical studies since 2010 and 10,000+ regulatory submissions.
- Serves six of the top ten pharmaceutical companies.
- Scaled to roughly 4,000 employees across the Americas, Europe, and Asia-Pacific.
- Expanded into Europe and North America through the acquisition of CROMSOURCE.

## Latest updates

- **2025-06** — Publicized completion of the CROMSOURCE acquisition, expanding ClinChoice's global presence across Europe and North America.
- **2023-03** — Announced acquisition of CROMSOURCE, an ISO-certified full-service CRO headquartered in Verona, Italy with US operations in Cary, NC.
- **2022-07** — Closed $150M Series E funding round led by Legend Capital to fund global expansion and acquisitions.
- **2020-09** — Fountain Medical Development and its affiliates rebranded as ClinChoice Inc.

## Links

- Website: https://clinchoice.com
- LinkedIn: https://www.linkedin.com/company/clinchoice
- Twitter/X: https://twitter.com/ClinChoice
- YouTube: https://youtube.com/channel/UC7XvyulVTckU9rHrvdwtkdA
- Facebook: https://facebook.com/clinchoiceofficial

---

Profile page: https://yespress.io/clinchoice
Published by YesPress — https://yespress.io
Last updated: 2026-06-15